Menu
Back to User profile » Professor Kamil Kuca
Papers published by Professor Kamil Kuca:
Mycology-Nanotechnology Interface: Applications in Medicine and Cosmetology
Dhanjal DS, Mehra P, Bhardwaj S, Singh R, Sharma P, Nepovimova E, Chopra C, Kuca K
International Journal of Nanomedicine 2022, 17:2505-2533
Published Date: 2 June 2022
Green Synthesis of Fe3O4 Nanoparticles Stabilized by a Garcinia mangostana Fruit Peel Extract for Hyperthermia and Anticancer Activities
Yusefi M, Shameli K, Su Yee O, Teow SY, Hedayatnasab Z, Jahangirian H, Webster TJ, Kuča K
International Journal of Nanomedicine 2021, 16:2515-2532
Published Date: 29 March 2021
Effect Of An Extra-Virgin Olive Oil Intake On The Delay Of Cognitive Decline: Role Of Secoiridoid Oleuropein?
Klimova B, Novotný M, Kuca K, Valis M
Neuropsychiatric Disease and Treatment 2019, 15:3033-3040
Published Date: 29 October 2019
Exploring assistive technology as a potential beneficial intervention tool for people with Alzheimer’s disease – a systematic review
Klimova B, Valis M, Kuca K
Neuropsychiatric Disease and Treatment 2018, 14:3151-3158
Published Date: 16 November 2018
Automatic epilepsy detection using fractal dimensions segmentation and GP–SVM classification
Jirka J, Prauzek M, Krejcar O, Kuca K
Neuropsychiatric Disease and Treatment 2018, 14:2439-2449
Published Date: 21 September 2018
Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisonings
Kuca K, Karasova JZ, Soukup O, Kassa J, Novotna E, Sepsova V, Horova A, Pejchal J, Hrabinova M, Vodakova E, Jun D, Nepovimova E, Valis M, Musilek K
Drug Design, Development and Therapy 2018, 12:505-512
Published Date: 9 March 2018
Bilingualism as a strategy to delay the onset of Alzheimer’s disease
Klimova B, Valis M, Kuca K
Clinical Interventions in Aging 2017, 12:1731-1737
Published Date: 19 October 2017
Cognitive decline in normal aging and its prevention: a review on non-pharmacological lifestyle strategies
Klimova B, Valis M, Kuca K
Clinical Interventions in Aging 2017, 12:903-910
Published Date: 25 May 2017
J-pouch versus Roux-en-Y reconstruction after gastrectomy: functional assessment and quality of life (randomized trial)
Zonca P, Maly T, Ihnat P, Peteja M, Kraft O, Kuca K
OncoTargets and Therapy 2017, 10:13-19
Published Date: 16 December 2016
Treatment cost of narcolepsy with cataplexy in Central Europe
Maresova P, Novotny M, Klímová B, Kuča K
Therapeutics and Clinical Risk Management 2016, 12:1709-1715
Published Date: 18 November 2016
Costs of inguinal hernia repair associated with using different medical devices in the Czech Republic
Marešová P, Peteja M, Lerch M, Zonca P, Kuca K
Therapeutics and Clinical Risk Management 2016, 12:1593-1597
Published Date: 26 October 2016
Prediction of population with Alzheimer's disease in the European Union using a system dynamics model
Tomaskova H, Kuhnova J, Cimler R, Dolezal O, Kuca K
Neuropsychiatric Disease and Treatment 2016, 12:1589-1598
Published Date: 30 June 2016
The influence of methods of bariatric surgery for treatment of type 2 diabetes mellitus
Bužga M, Maresova P, Seidlerová A, Zonča P, Holéczy P, Kuča K
Therapeutics and Clinical Risk Management 2016, 12:599-605
Published Date: 15 April 2016
Assistive technologies for managing language disorders in dementia
Klimova B, Maresova P, Kuca K
Neuropsychiatric Disease and Treatment 2016, 12:533-540
Published Date: 29 February 2016
The potential of medical device industry in technological and economical context
Maresova P, Penhaker M, Selamat A, Kuca K
Therapeutics and Clinical Risk Management 2015, 11:1505-1514
Published Date: 3 October 2015
Alzheimer's disease and its treatment costs: case study in the Czech Republic
Mohelska H, Maresova P, Valis M, Kuca K
Neuropsychiatric Disease and Treatment 2015, 11:2349-2354
Published Date: 11 September 2015
Alzheimer’s disease and language impairments: social intervention and medical treatment
Klimova B, Maresova P, Valis M, Hort J, Kuca K
Clinical Interventions in Aging 2015, 10:1401-1408
Published Date: 27 August 2015
Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
Masopust J, Andrýs C, Bažant J, Vyšata O, Kuca K, Vališ M
Neuropsychiatric Disease and Treatment 2015, 11:619-623
Published Date: 6 March 2015